C. Garrido

发表

Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

F. Garrido, A. Garcia-Lora, I. Algarra, 2009, Cancer Immunology, Immunotherapy.

Immunotherapy eradicates metastases with reversible defects in MHC class I expression

F. Garrido, A. Garcia-Lora, I. Algarra, 2011, Cancer Immunology, Immunotherapy.

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab

F. Garrido, A. Garcia-Lora, G. Garrido, 2017, Front. Pharmacol..

Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response

F. Novelli, A. Garcia-Lora, R. Accolla, 2014, Pancreas.

The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells

F. Garrido, A. Garcia-Lora, I. Algarra, 2012, The Journal of pathology.

MHC class I molecules act as tumor suppressor genes regulating the cell cycle gene expression, invasion and intrinsic tumorigenicity of melanoma cells.

F. Garrido, A. Garcia-Lora, I. Algarra, 2012, Carcinogenesis.

T lymphocytes restrain spontaneous metastases in permanent dormancy.

F. Garrido, A. Garcia-Lora, I. Algarra, 2014, Cancer research.

Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms

F. Garrido, L. E. Fernández, A. Garcia-Lora, 2014, Oncogene.

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy

F. Garrido, A. Garcia-Lora, I. Algarra, 2018, Front. Immunol..